Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs
Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more efficient approaches to generate and maintain patient-specific iPSCs. One approach is searching for compounds that influence pluripotent stem cell r...
Gespeichert in:
| Veröffentlicht in: | iScience Jg. 12; S. 168 - 181 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Elsevier
22.02.2019
|
| Schlagworte: | |
| ISSN: | 2589-0042, 2589-0042 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more efficient approaches to generate and maintain patient-specific iPSCs. One approach is searching for compounds that influence pluripotent stem cell reprogramming using functional screens of known drugs. Our high-throughput screening of drug-like hits showed that imidazopyridines-analogs of zolpidem, a sedative-hypnotic drug-are able to improve reprogramming efficiency and facilitate reprogramming of resistant human primary fibroblasts. The lead compound (O4I3) showed a remarkable OCT4 induction, which at least in part is due to the inhibition of H3K4 demethylase (KDM5, also known as JARID1). Experiments demonstrated that KDM5A, but not its homolog KDM5B, serves as a reprogramming barrier by interfering with the enrichment of H3K4Me3 at the OCT4 promoter. Thus our results introduce a new class of KDM5 chemical inhibitors and provide further insight into the pluripotency-related properties of KDM5 family members. |
|---|---|
| AbstractList | Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more efficient approaches to generate and maintain patient-specific iPSCs. One approach is searching for compounds that influence pluripotent stem cell reprogramming using functional screens of known drugs. Our high-throughput screening of drug-like hits showed that imidazopyridines-analogs of zolpidem, a sedative-hypnotic drug-are able to improve reprogramming efficiency and facilitate reprogramming of resistant human primary fibroblasts. The lead compound (O4I3) showed a remarkable OCT4 induction, which at least in part is due to the inhibition of H3K4 demethylase (KDM5, also known as JARID1). Experiments demonstrated that KDM5A, but not its homolog KDM5B, serves as a reprogramming barrier by interfering with the enrichment of H3K4Me3 at the OCT4 promoter. Thus our results introduce a new class of KDM5 chemical inhibitors and provide further insight into the pluripotency-related properties of KDM5 family members.Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more efficient approaches to generate and maintain patient-specific iPSCs. One approach is searching for compounds that influence pluripotent stem cell reprogramming using functional screens of known drugs. Our high-throughput screening of drug-like hits showed that imidazopyridines-analogs of zolpidem, a sedative-hypnotic drug-are able to improve reprogramming efficiency and facilitate reprogramming of resistant human primary fibroblasts. The lead compound (O4I3) showed a remarkable OCT4 induction, which at least in part is due to the inhibition of H3K4 demethylase (KDM5, also known as JARID1). Experiments demonstrated that KDM5A, but not its homolog KDM5B, serves as a reprogramming barrier by interfering with the enrichment of H3K4Me3 at the OCT4 promoter. Thus our results introduce a new class of KDM5 chemical inhibitors and provide further insight into the pluripotency-related properties of KDM5 family members. Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more efficient approaches to generate and maintain patient-specific iPSCs. One approach is searching for compounds that influence pluripotent stem cell reprogramming using functional screens of known drugs. Our high-throughput screening of drug-like hits showed that imidazopyridines—analogs of zolpidem, a sedative-hypnotic drug—are able to improve reprogramming efficiency and facilitate reprogramming of resistant human primary fibroblasts. The lead compound (O4I3) showed a remarkable OCT4 induction, which at least in part is due to the inhibition of H3K4 demethylase (KDM5, also known as JARID1). Experiments demonstrated that KDM5A, but not its homolog KDM5B, serves as a reprogramming barrier by interfering with the enrichment of H3K4Me3 at the OCT4 promoter. Thus our results introduce a new class of KDM5 chemical inhibitors and provide further insight into the pluripotency-related properties of KDM5 family members. • O4I3 supports the maintenance and generation of human iPSCs • O4I3 is a potent H3K4 demethylase KDM5 inhibitor in vitro and in cells • KDM5A, but not KDM5B, serves as an epigenetic barrier of reprogramming • Chemical or genetic inhibition of KDM5A tends to promote the reprogramming efficiency Biological Sciences; Biochemistry; Molecular Biology Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more efficient approaches to generate and maintain patient-specific iPSCs. One approach is searching for compounds that influence pluripotent stem cell reprogramming using functional screens of known drugs. Our high-throughput screening of drug-like hits showed that imidazopyridines-analogs of zolpidem, a sedative-hypnotic drug-are able to improve reprogramming efficiency and facilitate reprogramming of resistant human primary fibroblasts. The lead compound (O4I3) showed a remarkable OCT4 induction, which at least in part is due to the inhibition of H3K4 demethylase (KDM5, also known as JARID1). Experiments demonstrated that KDM5A, but not its homolog KDM5B, serves as a reprogramming barrier by interfering with the enrichment of H3K4Me3 at the OCT4 promoter. Thus our results introduce a new class of KDM5 chemical inhibitors and provide further insight into the pluripotency-related properties of KDM5 family members. Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more efficient approaches to generate and maintain patient-specific iPSCs. One approach is searching for compounds that influence pluripotent stem cell reprogramming using functional screens of known drugs. Our high-throughput screening of drug-like hits showed that imidazopyridines—analogs of zolpidem, a sedative-hypnotic drug—are able to improve reprogramming efficiency and facilitate reprogramming of resistant human primary fibroblasts. The lead compound (O4I3) showed a remarkable OCT4 induction, which at least in part is due to the inhibition of H3K4 demethylase (KDM5, also known as JARID1). Experiments demonstrated that KDM5A, but not its homolog KDM5B, serves as a reprogramming barrier by interfering with the enrichment of H3K4Me3 at the OCT4 promoter. Thus our results introduce a new class of KDM5 chemical inhibitors and provide further insight into the pluripotency-related properties of KDM5 family members. : Biological Sciences; Biochemistry; Molecular Biology Subject Areas: Biological Sciences, Biochemistry, Molecular Biology |
| Author | Wang, Jichang Gama-Brambila, Rodrigo A. Dabiri, Yasamin Reuter, Stefanie Adjaye, James Utikal, Jochen Mrowka, Ralf Herold, Kristina Cheng, Xinlai Taškova, Katerina Andrade-Navarro, Miguel A. |
| AuthorAffiliation | 7 Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510275, China 5 Institute for Stem Cell Research and Regenerative Medicine, Heinrich Heine University, 40225 Düsseldorf, Germany 2 Faculty of Biology, University Mainz, Gresemundweg 2, 55128 Mainz, Germany 1 Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, ImNeuenheimer Feld 364, 69120 Heidelberg, Germany 4 Experimentelle Nephrologie, KIM III, Universitätsklinikum, 07743 Jena, Germany 6 Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, 68167 Mannheim, Germany 3 Institute of Molecular Biology GmbH, Ackermannweg 4, 55128 Mainz, Germany |
| AuthorAffiliation_xml | – name: 1 Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, ImNeuenheimer Feld 364, 69120 Heidelberg, Germany – name: 6 Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, 68167 Mannheim, Germany – name: 7 Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510275, China – name: 5 Institute for Stem Cell Research and Regenerative Medicine, Heinrich Heine University, 40225 Düsseldorf, Germany – name: 4 Experimentelle Nephrologie, KIM III, Universitätsklinikum, 07743 Jena, Germany – name: 3 Institute of Molecular Biology GmbH, Ackermannweg 4, 55128 Mainz, Germany – name: 2 Faculty of Biology, University Mainz, Gresemundweg 2, 55128 Mainz, Germany |
| Author_xml | – sequence: 1 givenname: Yasamin surname: Dabiri fullname: Dabiri, Yasamin – sequence: 2 givenname: Rodrigo A. surname: Gama-Brambila fullname: Gama-Brambila, Rodrigo A. – sequence: 3 givenname: Katerina surname: Taškova fullname: Taškova, Katerina – sequence: 4 givenname: Kristina surname: Herold fullname: Herold, Kristina – sequence: 5 givenname: Stefanie surname: Reuter fullname: Reuter, Stefanie – sequence: 6 givenname: James surname: Adjaye fullname: Adjaye, James – sequence: 7 givenname: Jochen surname: Utikal fullname: Utikal, Jochen – sequence: 8 givenname: Ralf surname: Mrowka fullname: Mrowka, Ralf – sequence: 9 givenname: Jichang surname: Wang fullname: Wang, Jichang – sequence: 10 givenname: Miguel A. surname: Andrade-Navarro fullname: Andrade-Navarro, Miguel A. – sequence: 11 givenname: Xinlai orcidid: 0000-0001-6441-3742 surname: Cheng fullname: Cheng, Xinlai |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30685712$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UstuEzEUtVARLaU_wALNkk2Cff0YzwYJpYVGFLXisbY8HjtxNDMOtoOUfn09pFQti0pH8uucc617z2t0NIbRIvSW4DnBRHzYzH0yfg6YNHNMCuAFOgEumxnGDI4e7Y_RWUobjDEUsEa8QscUC8lrAidovRx8p2_Ddh9950ebKp2qm5DtmKuv5994dW4Hm9f7XidbLce1b30OsVBiGEL246r6brcxrKIehul04Zw33o5mXwVXXe4GPVb-5scivUEvne6TPbtfT9Gvzxc_F5ezq-svy8Wnq5lhQuYZgADDdWcldxYbsIDbjkPdCq4lB0MJbxlQajC0grq26bDh1MnSklrg1tFTtDz4dkFv1Db6Qce9CtqrvxchrpSO2ZveKqiJ1MYQQgRjuJGtY8QwYBI63QknitfHg9d21w62M6UpUfdPTJ--jH6tVuGPEpSzmk4G7-8NYvi9symroUzN9r0ebdglBaRuGCcUmkJ997jWQ5F_oyoEOBBMDClF6x4oBKspEmqjpkioKRIKk4JJJP8TGZ919mH6r--fk94Bw8K9iA |
| CitedBy_id | crossref_primary_10_3389_fgene_2024_1389558 crossref_primary_10_1016_j_ymthe_2020_08_014 crossref_primary_10_1186_s13045_021_01041_1 crossref_primary_10_1111_febs_15628 crossref_primary_10_1155_2020_4929053 crossref_primary_10_1007_s12015_021_10234_7 crossref_primary_10_1038_s41392_024_02039_0 crossref_primary_10_1038_s42003_019_0716_8 crossref_primary_10_1016_j_bcp_2025_117327 crossref_primary_10_1016_j_molstruc_2019_07_031 crossref_primary_10_1016_j_cellsig_2024_111046 crossref_primary_10_1007_s10517_023_05827_w crossref_primary_10_1371_journal_pcbi_1007351 crossref_primary_10_1083_jcb_202012097 crossref_primary_10_1016_j_chembiol_2021_04_018 crossref_primary_10_1155_2022_6472864 crossref_primary_10_1016_j_drudis_2023_103519 crossref_primary_10_1083_jcb_202006149 crossref_primary_10_3389_fonc_2019_00438 crossref_primary_10_1016_j_ejmech_2021_113855 crossref_primary_10_1016_j_ejmech_2023_115513 crossref_primary_10_1055_a_2058_0119 |
| Cites_doi | 10.1016/j.cell.2007.11.019 10.1016/j.stem.2010.12.001 10.1038/nrm3327 10.1073/pnas.1603668113 10.1038/nature11262 10.1038/nature19815 10.1016/S0149-2918(00)83024-6 10.1038/nature13804 10.1038/emboj.2011.383 10.1038/ncomms4678 10.1038/nrg.2017.57 10.4161/epi.5.8.13278 10.1242/dev.064741 10.1038/nature07056 10.1016/j.cell.2015.03.017 10.1093/molehr/4.11.1021 10.1038/nature09805 10.1038/nbt.3070 10.1021/acs.jmedchem.5b00226 10.1021/acs.accounts.7b00020 10.1038/nature09871 10.1038/nchembio.2087 10.1016/j.cell.2013.02.043 10.1038/nbt1310 10.1038/nature08180 10.1016/j.cell.2012.09.045 10.1016/j.stemcr.2013.08.007 10.1038/ng1783 10.1038/nature10953 10.1038/nature13551 10.1038/emboj.2011.91 10.1038/nature09229 10.1021/np5000796 10.1038/nchembio.2085 10.1126/science.1151526 10.1126/science.1239278 10.1038/74199 10.1038/nature12749 10.1038/nmeth.1591 10.1016/j.scr.2017.03.003 10.1038/ncomms3035 10.1038/ng.2491 10.1021/acs.jmedchem.5b00144 10.1021/jm300677j 10.1016/j.cell.2006.07.024 10.1016/j.stemcr.2017.10.001 10.1021/jo01373a021 10.1038/513481a |
| ContentType | Journal Article |
| Copyright | Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved. 2019 The Author(s) 2019 |
| Copyright_xml | – notice: Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved. – notice: 2019 The Author(s) 2019 |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.isci.2019.01.012 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2589-0042 |
| EndPage | 181 |
| ExternalDocumentID | oai_doaj_org_article_2718acc111644098bf41c42482dad6f6 PMC6354736 30685712 10_1016_j_isci_2019_01_012 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 53G AAEDW AALRI AAMRU AAXUO AAYWO AAYXX ABMAC ACVFH ADBBV ADCNI ADVLN AEUPX AEXQZ AFPUW AFTJW AIGII AITUG AKBMS AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BCNDV CITATION EBS EJD FDB GROUPED_DOAJ HYE M41 OK1 ROL RPM SSZ NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c468t-2262c5ade85fe0c2e20bd527b65a852c315b4233c02b63fb9d0c53f8016760bf3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 23 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000460603200014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2589-0042 |
| IngestDate | Fri Oct 03 12:52:38 EDT 2025 Tue Sep 30 16:02:31 EDT 2025 Fri Jul 11 10:40:05 EDT 2025 Mon Jul 21 05:47:40 EDT 2025 Thu Nov 13 04:36:49 EST 2025 Tue Nov 18 22:09:45 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Molecular Biology Biological Sciences Biochemistry |
| Language | English |
| License | Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c468t-2262c5ade85fe0c2e20bd527b65a852c315b4233c02b63fb9d0c53f8016760bf3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lead Contact |
| ORCID | 0000-0001-6441-3742 |
| OpenAccessLink | https://doaj.org/article/2718acc111644098bf41c42482dad6f6 |
| PMID | 30685712 |
| PQID | 2179451329 |
| PQPubID | 23479 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2718acc111644098bf41c42482dad6f6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6354736 proquest_miscellaneous_2179451329 pubmed_primary_30685712 crossref_primary_10_1016_j_isci_2019_01_012 crossref_citationtrail_10_1016_j_isci_2019_01_012 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-02-22 |
| PublicationDateYYYYMMDD | 2019-02-22 |
| PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-22 day: 22 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | iScience |
| PublicationTitleAlternate | iScience |
| PublicationYear | 2019 |
| Publisher | Elsevier |
| Publisher_xml | – name: Elsevier |
| References | Morizane (10.1016/j.isci.2019.01.012_bib20) 2013; 1 Takahashi (10.1016/j.isci.2019.01.012_bib38) 2016; 17 Kooistra (10.1016/j.isci.2019.01.012_bib16) 2012; 13 Hayashi (10.1016/j.isci.2019.01.012_bib11) 2016; 113 Schlaeger (10.1016/j.isci.2019.01.012_bib28) 2015; 33 Binda (10.1016/j.isci.2019.01.012_bib4) 2010; 5 Yu (10.1016/j.isci.2019.01.012_bib50) 2007; 318 Cheng (10.1016/j.isci.2019.01.012_bib8) 2015; 58 Takahashi (10.1016/j.isci.2019.01.012_bib35) 2007; 131 Wang (10.1016/j.isci.2019.01.012_bib42) 2014; 516 Schmitz (10.1016/j.isci.2019.01.012_bib29) 2011; 30 Koche (10.1016/j.isci.2019.01.012_bib15) 2011; 8 Shiba (10.1016/j.isci.2019.01.012_bib30) 2016; 538 Chen (10.1016/j.isci.2019.01.012_bib6) 2013; 45 Vassena (10.1016/j.isci.2019.01.012_bib40) 2011; 138 Yamanaka (10.1016/j.isci.2019.01.012_bib48) 2009; 460 Johansson (10.1016/j.isci.2019.01.012_bib14) 2016; 12 Okita (10.1016/j.isci.2019.01.012_bib22) 2011; 8 Gore (10.1016/j.isci.2019.01.012_bib10) 2011; 471 Baell (10.1016/j.isci.2019.01.012_bib3) 2014; 513 Kruidenier (10.1016/j.isci.2019.01.012_bib17) 2012; 488 Shore (10.1016/j.isci.2019.01.012_bib31) 2006; 38 Watanabe (10.1016/j.isci.2019.01.012_bib44) 2007; 25 Apostolou (10.1016/j.isci.2019.01.012_bib1) 2013; 502 Soufi (10.1016/j.isci.2019.01.012_bib34) 2015; 161 Buu-HoÏ (10.1016/j.isci.2019.01.012_bib5) 1954; 19 Smith (10.1016/j.isci.2019.01.012_bib32) 2016; 17 Soufi (10.1016/j.isci.2019.01.012_bib33) 2012; 151 Onder (10.1016/j.isci.2019.01.012_bib23) 2012; 483 Takahashi (10.1016/j.isci.2019.01.012_bib37) 2006; 126 Ma (10.1016/j.isci.2019.01.012_bib18) 2014; 511 Weitzel (10.1016/j.isci.2019.01.012_bib45) 2000; 22 Xie (10.1016/j.isci.2019.01.012_bib47) 2017; 50 Hou (10.1016/j.isci.2019.01.012_bib12) 2013; 341 Tan (10.1016/j.isci.2019.01.012_bib39) 2017; 9 Atlasi (10.1016/j.isci.2019.01.012_bib2) 2017; 18 Papp (10.1016/j.isci.2019.01.012_bib25) 2013; 152 Yamanaka (10.1016/j.isci.2019.01.012_bib49) 2010; 465 Takahashi (10.1016/j.isci.2019.01.012_bib36) 2014; 5 Wang (10.1016/j.isci.2019.01.012_bib43) 2013; 4 Hussein (10.1016/j.isci.2019.01.012_bib13) 2011; 471 Xie (10.1016/j.isci.2019.01.012_bib46) 2011; 30 Niwa (10.1016/j.isci.2019.01.012_bib21) 2000; 24 Ovitt (10.1016/j.isci.2019.01.012_bib24) 1998; 4 Rose (10.1016/j.isci.2019.01.012_bib27) 2012; 55 Pfaff (10.1016/j.isci.2019.01.012_bib26) 2017; 20 Mikkelsen (10.1016/j.isci.2019.01.012_bib19) 2008; 454 Vinogradova (10.1016/j.isci.2019.01.012_bib41) 2016; 12 Cheng (10.1016/j.isci.2019.01.012_bib7) 2015; 58 Cragg (10.1016/j.isci.2019.01.012_bib9) 2014; 77 |
| References_xml | – volume: 131 start-page: 861 year: 2007 ident: 10.1016/j.isci.2019.01.012_bib35 article-title: Induction of pluripotent stem cells from adult human fibroblasts by defined factors publication-title: Cell doi: 10.1016/j.cell.2007.11.019 – volume: 8 start-page: 96 year: 2011 ident: 10.1016/j.isci.2019.01.012_bib15 article-title: Reprogramming factor expression initiates widespread targeted chromatin remodeling publication-title: Cell Stem Cell doi: 10.1016/j.stem.2010.12.001 – volume: 13 start-page: 297 year: 2012 ident: 10.1016/j.isci.2019.01.012_bib16 article-title: Molecular mechanisms and potential functions of histone demethylases publication-title: Nature Rev. Mol. Cell Biol. doi: 10.1038/nrm3327 – volume: 113 start-page: 13057 year: 2016 ident: 10.1016/j.isci.2019.01.012_bib11 article-title: BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence publication-title: Proc.Natl.Acad.Sci. U S A doi: 10.1073/pnas.1603668113 – volume: 488 start-page: 404 year: 2012 ident: 10.1016/j.isci.2019.01.012_bib17 article-title: A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response publication-title: Nature doi: 10.1038/nature11262 – volume: 538 start-page: 388 year: 2016 ident: 10.1016/j.isci.2019.01.012_bib30 article-title: Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts publication-title: Nature doi: 10.1038/nature19815 – volume: 22 start-page: 1254 year: 2000 ident: 10.1016/j.isci.2019.01.012_bib45 article-title: Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia publication-title: Clin.Ther. doi: 10.1016/S0149-2918(00)83024-6 – volume: 17 start-page: 183 year: 2016 ident: 10.1016/j.isci.2019.01.012_bib38 article-title: A decade of transcription factor-mediated reprogramming to pluripotency. Nature reviews publication-title: Mol. Cell Biol. – volume: 516 start-page: 405 year: 2014 ident: 10.1016/j.isci.2019.01.012_bib42 article-title: Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells publication-title: Nature doi: 10.1038/nature13804 – volume: 30 start-page: 4586 year: 2011 ident: 10.1016/j.isci.2019.01.012_bib29 article-title: Jarid1b targets genes regulating development and is involved in neural differentiation publication-title: EMBO J. doi: 10.1038/emboj.2011.383 – volume: 5 start-page: 3678 year: 2014 ident: 10.1016/j.isci.2019.01.012_bib36 article-title: Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm publication-title: Nat.Commun. doi: 10.1038/ncomms4678 – volume: 18 start-page: 643 year: 2017 ident: 10.1016/j.isci.2019.01.012_bib2 article-title: The interplay of epigenetic marks during stem cell differentiation and development publication-title: Nat. Rev. Genet. doi: 10.1038/nrg.2017.57 – volume: 5 start-page: 767 year: 2010 ident: 10.1016/j.isci.2019.01.012_bib4 article-title: Trimethylation of histone H3 lysine 4 impairs methylation of histone H3 lysine 9: regulation of lysine methyltransferases by physical interaction with their substrates publication-title: Epigenetics doi: 10.4161/epi.5.8.13278 – volume: 138 start-page: 3699 year: 2011 ident: 10.1016/j.isci.2019.01.012_bib40 article-title: Waves of early transcriptional activation and pluripotency program initiation during human preimplantation development publication-title: Development doi: 10.1242/dev.064741 – volume: 454 start-page: 49 year: 2008 ident: 10.1016/j.isci.2019.01.012_bib19 article-title: Dissecting direct reprogramming through integrative genomic analysis publication-title: Nature doi: 10.1038/nature07056 – volume: 161 start-page: 555 year: 2015 ident: 10.1016/j.isci.2019.01.012_bib34 article-title: Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming publication-title: Cell doi: 10.1016/j.cell.2015.03.017 – volume: 4 start-page: 1021 year: 1998 ident: 10.1016/j.isci.2019.01.012_bib24 article-title: The molecular biology of Oct-4 in the early mouse embryo publication-title: Mol. Hum.Reprod. doi: 10.1093/molehr/4.11.1021 – volume: 471 start-page: 63 year: 2011 ident: 10.1016/j.isci.2019.01.012_bib10 article-title: Somatic coding mutations in human induced pluripotent stem cells publication-title: Nature doi: 10.1038/nature09805 – volume: 33 start-page: 58 year: 2015 ident: 10.1016/j.isci.2019.01.012_bib28 article-title: A comparison of non-integrating reprogramming methods publication-title: Nat.Biotechnol. doi: 10.1038/nbt.3070 – volume: 58 start-page: 5742 year: 2015 ident: 10.1016/j.isci.2019.01.012_bib8 article-title: Ethyl 2-((4-Chlorophenyl)amino)thiazole-4-carboxylate and derivatives are potent inducers of Oct3/4 publication-title: J. Med.Chem. doi: 10.1021/acs.jmedchem.5b00226 – volume: 17 start-page: 139 year: 2016 ident: 10.1016/j.isci.2019.01.012_bib32 article-title: Molecular features of cellular reprogramming and development. Nature reviews publication-title: Mol. Cell. Biol. – volume: 50 start-page: 1202 year: 2017 ident: 10.1016/j.isci.2019.01.012_bib47 article-title: Pharmacological reprogramming of somatic cells for regenerative medicine publication-title: Acc. Chem. Res. doi: 10.1021/acs.accounts.7b00020 – volume: 471 start-page: 58 year: 2011 ident: 10.1016/j.isci.2019.01.012_bib13 article-title: Copy number variation and selection during reprogramming to pluripotency publication-title: Nature doi: 10.1038/nature09871 – volume: 12 start-page: 539 year: 2016 ident: 10.1016/j.isci.2019.01.012_bib14 article-title: Structural analysis of human KDM5B guides histone demethylase inhibitor development publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2087 – volume: 152 start-page: 1324 year: 2013 ident: 10.1016/j.isci.2019.01.012_bib25 article-title: Epigenetics of reprogramming to induced pluripotency publication-title: Cell doi: 10.1016/j.cell.2013.02.043 – volume: 25 start-page: 681 year: 2007 ident: 10.1016/j.isci.2019.01.012_bib44 article-title: A ROCK inhibitor permits survival of dissociated human embryonic stem cells publication-title: Nat.Biotechnol. doi: 10.1038/nbt1310 – volume: 460 start-page: 49 year: 2009 ident: 10.1016/j.isci.2019.01.012_bib48 article-title: Elite and stochastic models for induced pluripotent stem cell generation publication-title: Nature doi: 10.1038/nature08180 – volume: 151 start-page: 994 year: 2012 ident: 10.1016/j.isci.2019.01.012_bib33 article-title: Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome publication-title: Cell doi: 10.1016/j.cell.2012.09.045 – volume: 1 start-page: 283 year: 2013 ident: 10.1016/j.isci.2019.01.012_bib20 article-title: Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2013.08.007 – volume: 38 start-page: 525 year: 2006 ident: 10.1016/j.isci.2019.01.012_bib31 article-title: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva publication-title: Nat. Genet. doi: 10.1038/ng1783 – volume: 483 start-page: 598 year: 2012 ident: 10.1016/j.isci.2019.01.012_bib23 article-title: Chromatin-modifying enzymes as modulators of reprogramming publication-title: Nature doi: 10.1038/nature10953 – volume: 511 start-page: 177 year: 2014 ident: 10.1016/j.isci.2019.01.012_bib18 article-title: Abnormalities in human pluripotent cells due to reprogramming mechanisms publication-title: Nature doi: 10.1038/nature13551 – volume: 30 start-page: 1473 year: 2011 ident: 10.1016/j.isci.2019.01.012_bib46 article-title: KDM5B regulates embryonic stem cell self-renewal and represses cryptic intragenic transcription publication-title: EMBO J. doi: 10.1038/emboj.2011.91 – volume: 465 start-page: 704 year: 2010 ident: 10.1016/j.isci.2019.01.012_bib49 article-title: Nuclear reprogramming to a pluripotent state by three approaches publication-title: Nature doi: 10.1038/nature09229 – volume: 77 start-page: 703 year: 2014 ident: 10.1016/j.isci.2019.01.012_bib9 article-title: New horizons for old drugs and drug leads publication-title: J. Nat. Prod. doi: 10.1021/np5000796 – volume: 12 start-page: 531 year: 2016 ident: 10.1016/j.isci.2019.01.012_bib41 article-title: An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2085 – volume: 318 start-page: 1917 year: 2007 ident: 10.1016/j.isci.2019.01.012_bib50 article-title: Induced pluripotent stem cell lines derived from human somatic cells publication-title: Science doi: 10.1126/science.1151526 – volume: 341 start-page: 651 year: 2013 ident: 10.1016/j.isci.2019.01.012_bib12 article-title: Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds publication-title: Science doi: 10.1126/science.1239278 – volume: 24 start-page: 372 year: 2000 ident: 10.1016/j.isci.2019.01.012_bib21 article-title: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells publication-title: Nat. Genet. doi: 10.1038/74199 – volume: 502 start-page: 462 year: 2013 ident: 10.1016/j.isci.2019.01.012_bib1 article-title: Chromatin dynamics during cellular reprogramming publication-title: Nature doi: 10.1038/nature12749 – volume: 8 start-page: 409 year: 2011 ident: 10.1016/j.isci.2019.01.012_bib22 article-title: A more efficient method to generate integration-free human iPS cells publication-title: Nat. Methods doi: 10.1038/nmeth.1591 – volume: 20 start-page: 70 year: 2017 ident: 10.1016/j.isci.2019.01.012_bib26 article-title: Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors publication-title: Stem Cell Res. doi: 10.1016/j.scr.2017.03.003 – volume: 4 start-page: 2035 year: 2013 ident: 10.1016/j.isci.2019.01.012_bib43 article-title: A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth publication-title: Nat.Commun. doi: 10.1038/ncomms3035 – volume: 45 start-page: 34 year: 2013 ident: 10.1016/j.isci.2019.01.012_bib6 article-title: H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs publication-title: Nat. Genet. doi: 10.1038/ng.2491 – volume: 58 start-page: 4976 year: 2015 ident: 10.1016/j.isci.2019.01.012_bib7 article-title: Identification of 2-[4-[(4-Methoxyphenyl)methoxy]-phenyl]acetonitrile and derivatives as potent Oct3/4 inducers publication-title: J. Med.Chem. doi: 10.1021/acs.jmedchem.5b00144 – volume: 55 start-page: 6639 year: 2012 ident: 10.1016/j.isci.2019.01.012_bib27 article-title: Plant growth regulator daminozide is a selective inhibitor of human KDM2/7 histone demethylases publication-title: J. Med.Chem. doi: 10.1021/jm300677j – volume: 126 start-page: 663 year: 2006 ident: 10.1016/j.isci.2019.01.012_bib37 article-title: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors publication-title: Cell doi: 10.1016/j.cell.2006.07.024 – volume: 9 start-page: 1721 year: 2017 ident: 10.1016/j.isci.2019.01.012_bib39 article-title: Naked mole rat cells have a stable epigenome that resists iPSC reprogramming publication-title: Stem Cell Rep. doi: 10.1016/j.stemcr.2017.10.001 – volume: 19 start-page: 1370 year: 1954 ident: 10.1016/j.isci.2019.01.012_bib5 article-title: 2-ARYLPYRROCOLINES AND 2-ARYLPYRIMIDAZOLES publication-title: J. Org. Chem. doi: 10.1021/jo01373a021 – volume: 513 start-page: 481 year: 2014 ident: 10.1016/j.isci.2019.01.012_bib3 article-title: Chemical con artists foil drug discovery publication-title: Nature doi: 10.1038/513481a |
| SSID | ssj0002002496 |
| Score | 2.215911 |
| Snippet | Pioneering human induced pluripotent stem cell (iPSC)-based pre-clinical studies have raised safety concerns and pinpointed the need for safer and more... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 168 |
| Title | Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30685712 https://www.proquest.com/docview/2179451329 https://pubmed.ncbi.nlm.nih.gov/PMC6354736 https://doaj.org/article/2718acc111644098bf41c42482dad6f6 |
| Volume | 12 |
| WOSCitedRecordID | wos000460603200014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Open Access Full Text customDbUrl: eissn: 2589-0042 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002002496 issn: 2589-0042 databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZp6KGXkpI-tmmDCrkVE1uyZPnY5kFCSVhIC3sTenYdGjvsbgrpr--M7F12Q2guBV9sS1gejaxP1jffEHLAGXehigaWqcZnmMM6M6yQmRAW4L0vg5Q-JZuoLi_VZFKP11J9ISeslwfuDXfI4ONpnIMhCTN3Xisby8KVrFTMGy9jEtsG1LO2mLpO22sohZcyywnkBIFrDhEzPbkLI16R11Unzc6CbcxKSbz_McT5kDi5NhOd7pCXA4SkX_qmvyJbod0l0_Obxps_3e39rPFIZadmTscdIOIF_XZ8IehxwGTR9wCWAz1vp41tMM8OHfd0vPYnBSjec7Vu8OwkSUtgXCbtIk2_-mkzvjqavyY_Tk--H51lQxaFzJVSLTLAV8wJ44MSMeSOBZZbL1hlpTBKMMcLYQFTcZczK3m0tc-d4FFhfILMbeRvyHbbteEdoV4IZ3nIvXShlLw03tYsYlVfM8_rESmWVtRukBjHTBe_9JJLdq3R8hotr_MCDjYin1d1bnuBjX-W_oqdsyqJ4tjpAriMHlxGP-UyI_Jp2bUaBhPukJg2dHdzzfDzJGCBDq_ytu_q1aNgbaVEhU2oNpxgoy2bd9pmmgS7AdSVFZfv_0fj98gLtEeKqmcfyPZidhc-kufu96KZz_bJs2qi9tNY-AtpLQv- |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Imidazopyridines+as+Potent+KDM5+Demethylase+Inhibitors+Promoting+Reprogramming+Efficiency+of+Human+iPSCs&rft.jtitle=iScience&rft.au=Dabiri%2C+Yasamin&rft.au=Gama-Brambila%2C+Rodrigo+A.&rft.au=Ta%C5%A1kova%2C+Katerina&rft.au=Herold%2C+Kristina&rft.date=2019-02-22&rft.pub=Elsevier&rft.eissn=2589-0042&rft.volume=12&rft.spage=168&rft.epage=181&rft_id=info:doi/10.1016%2Fj.isci.2019.01.012&rft_id=info%3Apmid%2F30685712&rft.externalDocID=PMC6354736 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2589-0042&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2589-0042&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2589-0042&client=summon |